Skip to Content

AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data

Thrasyvoulos Tzellos presents in this MEDtalk the results from a multinational prospective long-term study that assessed both efficacy and safety for treatment with dupilumab in real-world practice. According to Thrasyvoulos Tzellos, the study’s results are very promising in terms of safety.

Thrasyvoulos Tzellos

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top